We are live on ! Find out more
HRCM

Hood River Capital Management Portfolio holdings

AUM $9.98B
1-Year Est. Return 145.42%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+145.42%
3 Year Est. Return
+584.57%
5 Year Est. Return
+927.1%
10 Year Est. Return
+12,185.37%
AUM
$3.34B
AUM Growth
+$103M
Cap. Flow
-$73.7M
Cap. Flow %
-2.21%
Top 10 Hldgs %
31.01%
Holding
181
New
34
Increased
58
Reduced
45
Closed
34

Top Buys

Rank Stock Value
1
TNDM icon
Tandem Diabetes Care
TNDM
+$37.8M
2
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$27.3M
3
LPRO
Open Lending Corp
LPRO
+$22.9M
4
LNTH icon
Lantheus
LNTH
+$22.1M
5
BASE
Couchbase
BASE
+$20.9M

Top Sells

Rank Stock Value
1
UPBD icon
Upbound Group
UPBD
+$71.8M
2
KLIC icon
Kulicke & Soffa
KLIC
+$62.1M
3
SEM
Select Medical
SEM
+$47.2M
4
AZUL
Azul
AZUL
+$29.8M
5
MGNI icon
Magnite
MGNI
+$22.6M

Sector Composition

Rank Sector Weight
1 Technology 26.11%
2 Industrials 22.66%
3 Healthcare 18.78%
4 Consumer Discretionary 16.72%
5 Financials 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NICE icon
51
Nice
NICE
$6.01B
$25.3M 0.76%
83,473
-402
-0.5% -$116K
SSTK icon
52
Shutterstock
SSTK
$217M
$25.2M 0.76%
227,584
+23,937
+12% +$2.78M
SIMO icon
53
Silicon Motion
SIMO
$7.82B
$24.1M 0.72%
+253,790
New +$19.1M
LNTH icon
54
Lantheus
LNTH
$6.59B
$24M 0.72%
+831,329
New +$22.1M
ESTC icon
55
Elastic
ESTC
$7.93B
$24M 0.72%
194,980
+51,548
+36% +$7.79M
BASE
56
DELISTED
Couchbase
BASE
$23M 0.69%
923,209
+632,858
+218% +$20.9M
ARWR icon
57
Arrowhead Research
ARWR
$12.5B
$22.4M 0.67%
338,171
-563
-0.2% -$38.7K
BW icon
58
Babcock & Wilcox
BW
$1.32B
$22M 0.66%
2,443,298
-5,792
-0.2% -$46.4K
HCI icon
59
HCI Group
HCI
$2.36B
$20.8M 0.62%
249,393
-1,415
-0.6% -$165K
PRSU
60
Pursuit Attractions and Hospitality Inc
PRSU
$1.25B
$19.8M 0.59%
463,145
-2,142
-0.5% -$97.8K
TLS icon
61
Telos
TLS
$302M
$19.8M 0.59%
1,282,806
-214,033
-14% -$4.56M
FOLD
62
DELISTED
Amicus Therapeutics
FOLD
$19.8M 0.59%
1,711,710
-3,021
-0.2% -$33.7K
SAFE
63
DELISTED
Safehold Inc.
SAFE
$18.6M 0.56%
232,528
+7,983
+4% +$589K
TGTX icon
64
TG Therapeutics
TGTX
$7.52B
$18.3M 0.55%
963,762
+609,756
+172% +$15.8M
OCFC icon
65
OceanFirst Financial
OCFC
$1.87B
$17.8M 0.53%
+802,957
New +$17.5M
IART icon
66
Integra LifeSciences
IART
$1.33B
$17.3M 0.52%
258,975
-160,352
-38% -$10.8M
LAW icon
67
CS Disco
LAW
$271M
$17.1M 0.51%
478,060
+180,559
+61% +$8.01M
KRYS icon
68
Krystal Biotech
KRYS
$9.81B
$15.8M 0.47%
225,727
-174
-0.1% -$10.1K
KRTX
69
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$15.2M 0.46%
116,136
-73
-0.1% -$9.44K
NBIX icon
70
Neurocrine Biosciences
NBIX
$16.8B
$15.1M 0.45%
176,868
-1,849
-1% -$170K
CERS icon
71
Cerus
CERS
$508M
$14.5M 0.44%
2,134,280
-3,081
-0.1% -$20.7K
CLAR icon
72
Clarus
CLAR
$145M
$14.2M 0.43%
+511,921
New +$14.1M
IIIV icon
73
i3 Verticals
IIIV
$328M
$13.6M 0.41%
598,704
+127,131
+27% +$2.85M
INSM icon
74
Insmed
INSM
$29.4B
$12.2M 0.37%
449,136
+35
+0% +$1K
ARHS icon
75
Arhaus
ARHS
$1.34B
$11.8M 0.35%
+889,228
New +$9.81M
1 2
3
4 5

Similar funds

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return
URS
Utah Retirement Systems Salt Lake City, Utah $9.78B AUM 28.72% 1-Year Est. Return

Hood River Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Hood River Capital Management held 181 positions worth $3.34B, up 3.2% from $3.24B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Hood River Capital Management's Q4 2021 filing shows 34 new, 58 increased, 45 reduced and 34 closed positions. Its largest new stake was Tandem Diabetes Care: 279,895 shares worth $42.1M. The largest sale was Upbound Group, an estimated $71.8M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Industrials and Healthcare.

  • Hood River Capital Management's largest Q4 2021 buy was Tandem Diabetes Care: 279,895 shares worth $42.1M.
  • Hood River Capital Management added most to Biohaven Pharmaceutical Holding Company Ltd. in Q4 2021, an estimated $27.3M increase.
  • Hood River Capital Management's biggest Q4 2021 reduction was Select Medical, cutting an estimated $47.2M.
  • Hood River Capital Management fully exited Upbound Group in Q4 2021, selling an estimated $71.8M.
  • Hood River Capital Management's ten largest holdings make up 31% of its $3.34B portfolio in Q4 2021.
  • Hood River Capital Management opened 34 new positions and closed 34 in Q4 2021.
  • Hood River Capital Management's portfolio value rose 3.2% quarter-over-quarter to $3.34B.

Based on Hood River Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.